How Dynamic Muscle Cells Drive Coronary Artery Disease Risk

A new study in Nature Communications has uncovered how changes in vascular smooth muscle cells (VSMCs) affect the risk of coronary artery disease (CAD). Researchers used advanced techniques to track how these cells shift between different states, revealing links to inflammation and plaque instability.

The findings challenge older views of VSMCs as passive components in blood vessels. Instead, they show these cells play an active role in disease progression through dynamic state transitions.

The team combined single-cell transcriptomics, genetic data, and epigenetic analysis to map VSMC state transitions. They identified distinct cell states tied to higher CAD susceptibility, with some shifts promoting inflammation and weakening arterial plaques.

Genetic risk factors for CAD were found to influence key regulatory points in these transitions. This skews VSMC behaviour toward harmful phenotypes, worsening disease outcomes. In vivo experiments confirmed the existence of these cell states and their connection to lesion severity. Transcription factors like KLF4 and myocardin act as critical switches, controlling whether VSMCs remain stable or adopt pro-inflammatory roles. Epigenetic changes further lock these cells into detrimental states. The study also highlighted TGF-β and Notch signalling as major regulators of VSMC plasticity. These pathways could serve as targets for therapies aiming to restore healthy cell function and reduce CAD progression.

The research sets a new benchmark in cardiovascular studies by integrating multiple analytical approaches. It demonstrates that VSMC state trajectories directly shape plaque behaviour and disease risk.

These insights open potential avenues for treatments that recalibrate VSMC function, offering a more precise way to tackle coronary artery disease.